China · Delayed Price · Currency is CNY Theseus Pharmaceuticals Statistics
Total Valuation
SHE:300925 has a market cap or net worth of CNY 9.86 billion. The enterprise value is 9.00 billion.
| Market Cap | 9.86B |
| Enterprise Value | 9.00B |
Important Dates
The next estimated earnings date is Tuesday, August 26, 2025.
| Earnings Date | Aug 26, 2025 |
| Ex-Dividend Date | May 30, 2025 |
Share Statistics
SHE:300925 has 421.78 million shares outstanding. The number of shares has increased by 6.08% in one year.
| Current Share Class | 421.78M |
| Shares Outstanding | 421.78M |
| Shares Change (YoY) | +6.08% |
| Shares Change (QoQ) | +8.67% |
| Owned by Insiders (%) | 27.58% |
| Owned by Institutions (%) | 4.05% |
| Float | 265.83M |
Valuation Ratios
The trailing PE ratio is 78.18 and the forward PE ratio is 66.33.
| PE Ratio | 78.18 |
| Forward PE | 66.33 |
| PS Ratio | 2.24 |
| PB Ratio | 4.58 |
| P/TBV Ratio | 4.61 |
| P/FCF Ratio | 79.10 |
| P/OCF Ratio | 65.59 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 68.81, with an EV/FCF ratio of 72.20.
| EV / Earnings | 70.93 |
| EV / Sales | 2.05 |
| EV / EBITDA | 68.81 |
| EV / EBIT | 90.15 |
| EV / FCF | 72.20 |
Financial Position
The company has a current ratio of 4.04, with a Debt / Equity ratio of 0.08.
| Current Ratio | 4.04 |
| Quick Ratio | 3.73 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 1.28 |
| Debt / FCF | 1.34 |
| Interest Coverage | 25.61 |
Financial Efficiency
Return on equity (ROE) is 6.02% and return on invested capital (ROIC) is 2.66%.
| Return on Equity (ROE) | 6.02% |
| Return on Assets (ROA) | 2.19% |
| Return on Invested Capital (ROIC) | 2.66% |
| Return on Capital Employed (ROCE) | 4.64% |
| Revenue Per Employee | 181,746 |
| Profits Per Employee | 5,243 |
| Employee Count | 24,204 |
| Asset Turnover | 1.54 |
| Inventory Turnover | 50.16 |
Taxes
| Income Tax | -740,493 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +137.36% in the last 52 weeks. The beta is 1.05, so SHE:300925's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | +137.36% |
| 50-Day Moving Average | 23.70 |
| 200-Day Moving Average | 24.46 |
| Relative Strength Index (RSI) | 41.97 |
| Average Volume (20 Days) | 21,795,354 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300925 had revenue of CNY 4.40 billion and earned 126.90 million in profits. Earnings per share was 0.30.
| Revenue | 4.40B |
| Gross Profit | 846.81M |
| Operating Income | 99.84M |
| Pretax Income | 126.15M |
| Net Income | 126.90M |
| EBITDA | 107.71M |
| EBIT | 99.84M |
| Earnings Per Share (EPS) | 0.30 |
Balance Sheet
The company has 1.03 billion in cash and 167.19 million in debt, giving a net cash position of 860.90 million or 2.04 per share.
| Cash & Cash Equivalents | 1.03B |
| Total Debt | 167.19M |
| Net Cash | 860.90M |
| Net Cash Per Share | 2.04 |
| Equity (Book Value) | 2.15B |
| Book Value Per Share | 5.10 |
| Working Capital | 2.01B |
Cash Flow
In the last 12 months, operating cash flow was 150.34 million and capital expenditures -25.67 million, giving a free cash flow of 124.67 million.
| Operating Cash Flow | 150.34M |
| Capital Expenditures | -25.67M |
| Free Cash Flow | 124.67M |
| FCF Per Share | 0.30 |
Margins
Gross margin is 19.25%, with operating and profit margins of 2.27% and 2.88%.
| Gross Margin | 19.25% |
| Operating Margin | 2.27% |
| Pretax Margin | 2.87% |
| Profit Margin | 2.88% |
| EBITDA Margin | 2.45% |
| EBIT Margin | 2.27% |
| FCF Margin | 2.83% |
Dividends & Yields
This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 0.27%.
| Dividend Per Share | 0.07 |
| Dividend Yield | 0.27% |
| Dividend Growth (YoY) | -18.75% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 28.66% |
| Buyback Yield | -6.08% |
| Shareholder Yield | -5.81% |
| Earnings Yield | 1.29% |
| FCF Yield | 1.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 17, 2022. It was a forward split with a ratio of 1.7.
| Last Split Date | Jun 17, 2022 |
| Split Type | Forward |
| Split Ratio | 1.7 |
Scores
SHE:300925 has an Altman Z-Score of 9.76 and a Piotroski F-Score of 6.
| Altman Z-Score | 9.76 |
| Piotroski F-Score | 6 |